SAB Biotherapeutics, Inc. (SABS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 112.78M | 101.05M | 113.28M | 9.31M | 16.3M | 23.79M | 32.54M | 39.58M | 46.95M | 58.91M | 3.13M | 9.01M |
| Cash & Short-Term Investments | 107.39M | 96.59M | 110.88M | 5.71M | 12.85M | 20.76M | 30.4M | 37.33M | 44.06M | 56.57M | 2.43M | 7.77M |
| Cash Only | 20.52M | 10.5M | 29.42M | 3.69M | 5.64M | 8.9M | 9.17M | 17.24M | 14.03M | 56.57M | 2.43M | 7.77M |
| Short-Term Investments | 86.87M | 86.09M | 81.46M | 2.02M | 7.21M | 11.86M | 21.23M | 20.08M | 30.02M | 0 | 0 | 0 |
| Accounts Receivable | 1.56M | 946.78K | 559.95K | 0 | 21.39K | 54.95K | 97.05K | 224.92K | 193.23K | 0 | 0 | 364.12K |
| Days Sales Outstanding | - | - | - | - | - | 60.96 | - | 72.3 | 18.62 | - | - | 599.75 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.84M | 3.51M | 1.84M | 3.59M | 3.42M | 2.98M | 2.04M | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 135.69M | 71.76M | 70.17M | 20.82M | 21.82M | 20.4M | 21.26M | 22.31M | 24.42M | 25.03M | 25.21M | 26.44M |
| Property, Plant & Equipment | 20.17M | 19.4M | 19.44M | 20.4M | 21.37M | 19.92M | 20.75M | 21.79M | 22.63M | 24.68M | 24.84M | 26M |
| Fixed Asset Turnover | - | - | - | - | - | 0.01x | - | 0.01x | 0.04x | 0.01x | 0.05x | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 110.24M | 46.89M | 50.61M | 0 | 0 | 0 | 0 | 0 | 1.24M | 0 | 0 | 0 |
| Other Non-Current Assets | 5.28M | 5.46M | 124.07K | 417.49K | 449.79K | 482.1K | 514.41K | 521.72K | 554.03K | 350.23K | 371.19K | 434K |
| Total Assets | 248.47M | 172.81M | 183.45M | 30.13M | 38.12M | 44.2M | 53.8M | 61.89M | 71.37M | 83.94M | 28.34M | 35.44M |
| Asset Turnover | - | - | - | - | - | 0.00x | - | 0.00x | 0.01x | 0.01x | 0.04x | 0.00x |
| Asset Growth % | 551.81% | 291.01% | 241% | -51.32% | -46.59% | -47.35% | 89.85% | 74.63% | 67.25% | 64.9% | -46.03% | -40.09% |
| Total Current Liabilities | 9.85M | 10.68M | 10.79M | 10.68M | 9.65M | 7.98M | 8.82M | 7.55M | 8.3M | 10.81M | 9.21M | 11.01M |
| Accounts Payable | 3.54M | 3.15M | 2.95M | 2.62M | 2.52M | 1.69M | 1.3M | 1.17M | 1.24M | 945.93K | 1.08M | 1.4M |
| Days Payables Outstanding | 400.02 | 367.66 | 335.16 | 284.67 | - | 175.15 | 117.43 | 107.35 | 50.11 | 98.83 | 116.09 | 145.27 |
| Short-Term Debt | 920.66K | 0 | 0 | 0 | 138.55K | 811.84K | 0 | 615.82K | 835.47K | 1.05M | 541.64K | 784.88K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 114.7K | 114.7K | 377.83K | 1.32M | 1.63M | 2.89M |
| Other Current Liabilities | 5.39M | 0 | 0 | 0 | 0 | 5.47M | 0 | 1.01M | 1.28M | 4.49M | 4.43M | 4.22M |
| Current Ratio | 11.45x | 9.46x | 10.50x | 0.87x | 1.69x | 2.98x | 3.69x | 5.24x | 5.65x | 5.45x | 0.34x | 0.82x |
| Quick Ratio | 11.45x | 9.46x | 10.50x | 0.87x | 1.69x | 2.98x | 3.69x | 5.24x | 5.65x | 5.45x | 0.34x | 0.82x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 11.37M | 10.63M | 7.58M | 7.44M | 7.06M | 10.25M | 8.08M | 8.22M | 10.24M | 15.83M | 3.87M | 4.72M |
| Long-Term Debt | 5.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 541.64K |
| Capital Lease Obligations | 0 | 5M | 5.2M | 5.46M | 5.71M | 3.86M | 4M | 4.13M | 3.94M | 4.05M | 3.45M | 3.58M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6.12M | 5.64M | 2.38M | 1.98M | 1.35M | 6.39M | 4.08M | 4.09M | 6.31M | 11.77M | 417.1K | 595.86K |
| Total Liabilities | 21.22M | 21.32M | 18.37M | 18.11M | 16.71M | 18.23M | 16.89M | 15.77M | 18.55M | 26.64M | 13.08M | 15.73M |
| Total Debt | 6.17M | 5.95M | 6.19M | 6.42M | 6.78M | 4.67M | 4.52M | 5.34M | 5.45M | 5.91M | 4.65M | 5.58M |
| Net Debt | -14.35M | -4.55M | -23.24M | 2.73M | 1.14M | -4.23M | -4.65M | -11.9M | -8.58M | -50.66M | 2.23M | -2.2M |
| Debt / Equity | 0.03x | 0.04x | 0.04x | 0.53x | 0.32x | 0.18x | 0.12x | 0.12x | 0.10x | 0.10x | 0.30x | 0.28x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -318.72x | -264.68x | 1050.74x | -156.19x | -73.70x | -159.77x | -131.62x | -77.78x | -64.81x | -292.49x | -72.21x | -90.36x |
| Total Equity | 227.25M | 151.49M | 165.07M | 12.02M | 21.41M | 25.97M | 36.9M | 46.12M | 52.82M | 57.3M | 15.26M | 19.72M |
| Equity Growth % | 961.54% | 483.35% | 347.32% | -73.95% | -59.47% | -54.68% | 141.89% | 133.92% | 116.46% | 84.49% | -50.18% | -46.89% |
| Book Value per Share | 4.24 | 2.47 | 2.12 | 1.29 | 2.30 | 2.80 | 3.99 | 4.98 | 5.72 | 9.67 | 2.91 | 3.91 |
| Total Shareholders' Equity | 227.25M | 151.49M | 165.07M | 12.02M | 21.41M | 25.97M | 36.9M | 46.12M | 52.82M | 57.3M | 15.26M | 19.72M |
| Common Stock | 7.58K | 4.77K | 4.76K | 936 | 936 | 935 | 929 | 929 | 929 | 929 | 5.29K | 5.29K |
| Retained Earnings | -129.76M | -110.9M | -94.03M | -139.48M | -129.37M | -124.17M | -112.77M | -102.42M | -95.09M | -90.06M | -67.21M | -62.1M |
| Treasury Stock | 0 | -5.52M | -5.52M | -5.52M | -5.52M | -5.52M | -5.52M | -5.52M | -5.52M | -5.52M | -5.52M | -5.52M |
| Accumulated OCI | -222.76K | 186.51K | 71.22K | -15.8K | -111.59K | -135.41K | 52.13K | -31.35K | -63.45K | 26.42K | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |